Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

What evidence supports cyclical versus continuous TB-500 use?

TB-500 protocols are cycled rather than run continuously. The standard structure is 6–8 weeks on, followed by 4–8 weeks off before a repeat where needed. Cycling leaves a window to read whether the peptide is contributing to recovery and avoids prolonged use.

This comparison does not assign a generated winner or score.

  • TB-500 protocols are cycled rather than run continuously. The standard structure is 6–8 weeks on, followed by 4–8 weeks off before a repeat where needed. Cycling leaves a window to read whether the peptide is contributing to recovery and avoids prolonged use. TB-500 is a repair signal, not a maintenance compound — once tissue remodeling is underway, continued dosing has diminishing returns.
More references

Related material

Comparison

11. TB-500 vs full-length TB-4

TB-500 (synthetic active-region analogue) and full-length recombinant TB-4 differ in: Size and molecular weight: TB-500 is a shorter peptide (typically ~17 amino acids vs TB-4’s 4…

View details →